FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:634-636 February 9, 2006 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Bonner, J. A. PubMed Citation

The treatment of head and neck cancer is complex and difficult, both technically and physically. Tumors in each site in the head and neck (oropharynx, hypopharynx, larynx, and oral cavity) have the same squamous tissue and biologic features, but their clinical presentation and responses to therapy differ according to site. In addition to this level of complexity, there is the inescapable fact that structures of the head and neck control essential, continuously operational functions: speech, swallowing, eating, and breathing. This fact means that the short-term and long-term side effects of treatment can profoundly affect the quality of life.

Even so, . . . [Full Text of this Article]

Source Information

From the Division of Adult Oncology, Dana–Farber Cancer Institute; the Department of Medicine, Brigham and Women's Hospital; and Harvard Medical School — all in Boston.

This article has been cited by other articles:

• Ang, K. K. (2008). Multidisciplinary Management of Locally Advanced SCCHN: Optimizing Treatment Outcomes. The Oncologist 13: 899-910 [Abstract] [Full Text]  
• Sharkey, R. M. (2006). Radioimmunotherapy Against the Tumor Vasculature: A New Target?. JNM 47: 1070-1074 [Full Text]  
• Stinchcombe, T. E., Fried, D., Morris, D. E., Socinski, M. A. (2006). Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer. The Oncologist 11: 809-823 [Abstract] [Full Text]